No definitive diagnostic test exists for Burkholderia, a category B agent caused by Burkholderia pseudomallei bacterium, which poses a threat to deployed servicemembers. The Defense Threat Reduction Agency’s Chemical and Biological Technologies [Read more]
The Enhanced Maritime Biological Detection (EMBD) program is charged with finalizing development, and complete testing, integration and production of an automated biological warfare agent point detection system. The EMBD program has issued [Read more]
Emergent BioSolutions Inc. today announced that it has been awarded approximately $23 million to develop a novel multi-drug auto-injector for nerve agent antidote delivery. Emergent’s device is being designed for intramuscular self- [Read more]
A large stainless steel time capsule emblazoned with the logo of the U.S. Army Edgewood Chemical Biological Center (ECBC) shared the stage with federal, state, and local officials and leaders within the [Read more]
The Defense Threat Reduction Agency Joint Science and Technology Office’s (JSTO) Toxicant Penetration and Scavenging (TPS) research program, managed by Brian Pate, Ph.D., explores countermeasure development for increased protection against chemical and biological weapons. [Read more]
The US Army Engineer Research and Development Center (ERDC) has awarded a contract to Science Policy Consulting, LLC to identify knowledge and data gaps related to understanding the possible environmental impacts of [Read more]
The U.S. Department of Defense Tick-Borne Disease Research Program (TBDRP) aims to prevent tick-borne diseases and better diagnose and resolve associated illnesses. TBDRP was established in FY 2016 to support innovative and impactful research that addresses [Read more]
The Defense Advanced Research Projects Agency (DARPA) has awarded a cooperative agreement to Massachusetts General Hospital for research and development supporting the Safe Genes program. The Safe Genes program aims to deliver [Read more]
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Virology Division, Pathogenesis and Immunology Branch has been tasked by the Defense Threat Reduction Agency to investigate a potential for enhanced efficacy [Read more]
The U.S. Army Medical Research and Materiel Command (USAMRMC) Special Immunizations Program (SIP) currently offers Investigational New Drug (IND) products to both military and civilian personnel at risk for pathogen and toxin exposure. [Read more]
© 2017 Global Biodefense